Status:
UNKNOWN
Surgical Ovarian Drilling Versus Hormonal Treatment for Infertility Associated to PolyCystic Ovaries Syndrome (PCOS)
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Hopital Antoine Beclere
Hôpital Jean Verdier
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
18-36 years
Phase:
PHASE4
Brief Summary
PolysCsytic Ovaries Syndrome (PCOS) is the most frequent endocrinopathy. The first stage of infertility treatment is Clomiphene Citrate which leads to 50 % pregnancies. In case of failure, it is possi...
Detailed Description
PolysCsytic Ovaries Syndrome (PCOS) is the most frequent endocrinopathy. The first stage of infertility treatment is Clomiphene Citrate which leads to 50 % pregnancies. In case of failure, it is possi...
Eligibility Criteria
Inclusion
- Age between 18 and 36 years old
- Female patient with PCOS (Rotterdam criteria)
- Failure of treatment with Clomiphene Citrate
- Informed consent
- Female patient with medical assurance
- Patient in failure with PCOS and Clomiphene citrate
Exclusion
- Female patient is over 36 years old
- Thyroid disease (4\<TSH\<0.3 mUI/L)
- Virilizing tumor
- FERTILOSCOPY non possible (Douglas cul de sac clinically fixed)
- Anormality of SPERMOGRAM (abnormal time of migration of survival)
- Prolactin \> 1.5 N
- Anormality of 17-OH Progesterone (\<2 ng/mL)
- Fallopian tubes non permeable TMS\< 5 Millions
- Female patient participant or have been participated to another clinical trial during the last month before the inclusion
- Female patient without medical assurance
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2011
Estimated Enrollment :
252 Patients enrolled
Trial Details
Trial ID
NCT00378729
Start Date
October 1 2006
End Date
October 1 2011
Last Update
October 4 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Antoine Beclere
Clamart, France, 92170